Siegemund M - Search Results

1

Antitumor Activity of a Mesenchymal Stem Cell Line Stably Secreting a Tumor-Targeted TNF-Related Apoptosis-Inducing Ligand Fusion Protein.

Marini I, Siegemund M, Hutt M, Kontermann RE, Pfizenmaier K. Marini I, et al. Among authors: siegemund m. Front Immunol. 2017 May 11;8:536. doi: 10.3389/fimmu.2017.00536. eCollection 2017. Front Immunol. 2017. PMID: 28553285 Free PMC article.

2

Superior antitumoral activity of dimerized targeted single-chain TRAIL fusion proteins under retention of tumor selectivity.

Siegemund M, Pollak N, Seifert O, Wahl K, Hanak K, Vogel A, Nussler AK, Göttsch D, Münkel S, Bantel H, Kontermann RE, Pfizenmaier K. Siegemund M, et al. Cell Death Dis. 2012 Apr 12;3(4):e295. doi: 10.1038/cddis.2012.29. Cell Death Dis. 2012. PMID: 22495350 Free PMC article.

3

Increased apoptosis induction in hepatocellular carcinoma by a novel tumor-targeted TRAIL fusion protein combined with bortezomib.

Wahl K, Siegemund M, Lehner F, Vondran F, Nüssler A, Länger F, Krech T, Kontermann R, Manns MP, Schulze-Osthoff K, Pfizenmaier K, Bantel H. Wahl K, et al. Among authors: siegemund m. Hepatology. 2013 Feb;57(2):625-36. doi: 10.1002/hep.26082. Epub 2013 Jan 8. Hepatology. 2013. PMID: 22991197

4

Tetravalent antibody-scTRAIL fusion proteins with improved properties.

Seifert O, Plappert A, Fellermeier S, Siegemund M, Pfizenmaier K, Kontermann RE. Seifert O, et al. Among authors: siegemund m. Mol Cancer Ther. 2014 Jan;13(1):101-11. doi: 10.1158/1535-7163.MCT-13-0396. Epub 2013 Oct 3. Mol Cancer Ther. 2014. PMID: 24092811

5

EGFR-targeted TRAIL and a Smac mimetic synergize to overcome apoptosis resistance in KRAS mutant colorectal cancer cells.

Möller Y, Siegemund M, Beyes S, Herr R, Lecis D, Delia D, Kontermann R, Brummer T, Pfizenmaier K, Olayioye MA. Möller Y, et al. Among authors: siegemund m. PLoS One. 2014 Sep 8;9(9):e107165. doi: 10.1371/journal.pone.0107165. eCollection 2014. PLoS One. 2014. PMID: 25198428 Free PMC article.

6

An optimized antibody-single-chain TRAIL fusion protein for cancer therapy.

Siegemund M, Seifert O, Zarani M, Džinić T, De Leo V, Göttsch D, Münkel S, Hutt M, Pfizenmaier K, Kontermann RE. Siegemund M, et al. MAbs. 2016 Jul;8(5):879-91. doi: 10.1080/19420862.2016.1172163. Epub 2016 Apr 11. MAbs. 2016. PMID: 27064440 Free PMC article.

7

Superior Properties of Fc-comprising scTRAIL Fusion Proteins.

Hutt M, Marquardt L, Seifert O, Siegemund M, Müller I, Kulms D, Pfizenmaier K, Kontermann RE. Hutt M, et al. Among authors: siegemund m. Mol Cancer Ther. 2017 Dec;16(12):2792-2802. doi: 10.1158/1535-7163.MCT-17-0551. Epub 2017 Sep 13. Mol Cancer Ther. 2017. PMID: 28904131

8

IgG-single-chain TRAIL fusion proteins for tumour therapy.

Siegemund M, Schneider F, Hutt M, Seifert O, Müller I, Kulms D, Pfizenmaier K, Kontermann RE. Siegemund M, et al. Sci Rep. 2018 May 17;8(1):7808. doi: 10.1038/s41598-018-24450-8. Sci Rep. 2018. PMID: 29773864 Free PMC article.

9

Systemic network analysis identifies XIAP and IκBα as potential drug targets in TRAIL resistant BRAF mutated melanoma.

Del Mistro G, Lucarelli P, Müller I, De Landtsheer S, Zinoveva A, Hutt M, Siegemund M, Kontermann RE, Beissert S, Sauter T, Kulms D. Del Mistro G, et al. Among authors: siegemund m. NPJ Syst Biol Appl. 2018 Nov 5;4:39. doi: 10.1038/s41540-018-0075-y. eCollection 2018. NPJ Syst Biol Appl. 2018. PMID: 30416750 Free PMC article.

10

A TNF receptor 2 selective agonist rescues human neurons from oxidative stress-induced cell death.

Fischer R, Maier O, Siegemund M, Wajant H, Scheurich P, Pfizenmaier K. Fischer R, et al. Among authors: siegemund m. PLoS One. 2011;6(11):e27621. doi: 10.1371/journal.pone.0027621. Epub 2011 Nov 14. PLoS One. 2011. PMID: 22110694 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

198 results

Search Page